HUMACYTE INC. - COMMO
5.5000
07-October-24 14:59:59
15 minutes delayed
Stocks
+0.0600
+1.10%
Today's range
5.3700 - 5.7150
ISIN
N/A
Source
NASDAQ
-
Humacyte Expands Board of Directors and Leadership Team with New Appointments
20 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
09 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
Humacyte Presents at Multiple Conferences in September 2022
08 Sep 2022 07:01:00 By Nasdaq GlobeNewswire
-
Humacyte Second Quarter 2022 Financial Results and Business Update
12 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
05 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
25 Jul 2022 19:26:26 By Nasdaq GlobeNewswire
-
19 Jul 2022 07:00:02 By Nasdaq GlobeNewswire
-
07 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
29 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.
27 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
21 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
Humacyte Presents New Immunogenicity Data on Human Acellular Vessels™ (HAVs™)
08 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Humacyte to Present at the H.C. Wainwright Global Investment Conference
16 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
Humacyte First Quarter 2022 Financial Results and Business Update
13 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
09 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
06 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
05 Apr 2022 07:00:03 By Nasdaq GlobeNewswire
-
Humacyte Announces Date of Annual Shareholder Meeting
04 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
29 Mar 2022 06:00:01 By Nasdaq GlobeNewswire